Cargando…
Serum glial fibrillary acidic protein indicates memory impairment in patients with chronic heart failure
AIMS: Cognitive dysfunction occurs frequently in patients with heart failure (HF), but early detection remains challenging. Serum glial fibrillary acidic protein (GFAP) is an emerging biomarker of cognitive decline in disorders of primary neurodegeneration such as Alzheimer's disease. We evalua...
Autores principales: | Traub, Jan, Otto, Markus, Sell, Roxane, Homola, György A., Steinacker, Petra, Oeckl, Patrick, Morbach, Caroline, Frantz, Stefan, Pham, Mirko, Störk, Stefan, Stoll, Guido, Frey, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288738/ https://www.ncbi.nlm.nih.gov/pubmed/35611842 http://dx.doi.org/10.1002/ehf2.13986 |
Ejemplares similares
-
Serum phosphorylated tau protein 181 and neurofilament light chain in cognitively impaired heart failure patients
por: Traub, Jan, et al.
Publicado: (2022) -
Profiles of cognitive impairment in chronic heart failure—A cluster analytic approach
por: Göpfert, Dennis, et al.
Publicado: (2023) -
Sustained Increase in Serum Glial Fibrillary Acidic Protein after First ST-Elevation Myocardial Infarction
por: Traub, Jan, et al.
Publicado: (2022) -
Internal carotid artery blood flow and pulsatility index in cognitively impaired people with chronic heart failure
por: Traub, Jan, et al.
Publicado: (2023) -
Serum β-synuclein, neurofilament light chain and glial fibrillary acidic protein as prognostic biomarkers in moderate-to-severe acute ischemic stroke
por: Barba, Lorenzo, et al.
Publicado: (2023)